Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EXEL · against 1,372 other Healthcare companies
Ranked #404 of 1,373 · scores higher than 71% of peers · safety percentile 71
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 70–79, including EXEL · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | EXEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.09× | 0.24× | 68% | 33% | |
| BetaLower is better · 1,320 reported | 0.47 | 0.53 | 55% | 33% | |
| Current ratioHigher is better · 1,338 reported | 3.46× | 2.62× | 61% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 400 | 29.2B CNY (≈$4.1B) | 71 | 42 | |
| 401 | 6.5B CNY (≈$908M) | 71 | 62 | |
| 402 | 11.1B CNY (≈$1.6B) | 71 | 72 | |
| 403 | 12.3B CNY (≈$1.7B) | 71 | 85 | |
| 404 | 17.9B USD | 71 | 76 | |
| 405 | 326M EUR (≈$359M) | 71 | 75 | |
| 406 | 6.0B CNY (≈$840M) | 70 | 45 | |
| 407 | 2.3B CNY (≈$323M) | 70 | 40 | |
| 408 | 2.4B SGD (≈$1.8B) | 70 | 79 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score